Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

VACUETTE¿ Blood Collection tube 9NC Coagulation sodium citrate 3.2% 13x75 Recalled by Greiner Bio-One North America, Inc. Due to VACUETTE¿ Blood Collection tube 9NC Coagulation sodium citrate...

Date: March 29, 2021
Company: Greiner Bio-One North America, Inc.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Greiner Bio-One North America, Inc. directly.

Affected Products

VACUETTE¿ Blood Collection tube 9NC Coagulation sodium citrate 3.2% 13x75 blue cap-white ring, sandwich tube, non-ridged - Product Usage: indicated for use in collection and transport of venous whole blood for coagulation testing.

Quantity: 1,049,700 units

Why Was This Recalled?

VACUETTE¿ Blood Collection tube 9NC Coagulation sodium citrate 3.2% may show insufficient draw volume of the tubes, which could produce erroneous results for prothrombin time, activated partial thromboplastin time, and fibrinogen assays.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Greiner Bio-One North America, Inc.

Greiner Bio-One North America, Inc. has 16 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report